Suchergebnisse - "Ong, SuFey"

PubPharm (37)

1

CD39 and LDHA affects the prognostic role of NLR in metastatic melanoma patients treated with immunotherapy

enthalten in: Journal of translational medicine | 2023

von Mallardo, D. | Fordellone, M. | White, A. | +15

2

CD39 and LDHA affects the prognostic role of NLR in metastatic melanoma patients treated with immunotherapy

enthalten in: Journal of translational medicine | 2023

von Mallardo, D. | Fordellone, M. | White, A. | +15

3

CD39 and LDHA affects the prognostic role of NLR in metastatic melanoma patients treated with immunotherapy

enthalten in: Journal of translational medicine | 2023

von Mallardo, D. | Fordellone, M. | White, A. | +15

4

Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12

enthalten in: Immunity | 2022

von Garris, C. | Arlauckas, S. | Kohler, R. | +20

ErratumFor: Immunity. 2018 Dec 18;49(6):1148-1161.e7. - PMID 30552023

5

A PD-1/PD-L1 Proximity Assay as a Theranostic Marker for PD-1 Blockade in Patients with Metastatic Melanoma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von Girault, I. | Adam, J. | Shen, S. | +12

6

A monocentric phase I study of vemurafenib plus cobimetinib plus PEG-interferon (VEMUPLINT) in advanced melanoma patients harboring the V600BRAF mutation

enthalten in: Journal of translational medicine | 2021

von Simeone, E. | Scognamiglio, G. | Capone, M. | +15

7

A monocentric phase I study of vemurafenib plus cobimetinib plus PEG-interferon (VEMUPLINT) in advanced melanoma patients harboring the V600BRAF mutation

enthalten in: Journal of translational medicine | 2021

von Simeone, E. | Scognamiglio, G. | Capone, M. | +15

8

B cells and tertiary lymphoid structures promote immunotherapy response

enthalten in: Nature | 2020

von Helmink, B. | Reddy, S. | Gao, J. | +57

CommentIn: Nature. 2020 Jan;577(7791):474-476. - PMID 31965091

9

Restricting Glycolysis Preserves T Cell Effector Functions and Augments Checkpoint Therapy

enthalten in: Cell reports | 2019

von Renner, K. | Bruss, C. | Schnell, A. | +39

10

Publisher Correction : Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial

enthalten in: Nature medicine | 2019

von Voorwerk, L. | Slagter, M. | Horlings, H. | +31

ErratumFor: Nat Med. 2019 Jun;25(6):920-928. - PMID 31086347